Alzheimers Disease Research: What Has Guided Research So Far and Why It Is High Time for a Paradigm Shift | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
A01=Christian Behl
Age Group_Uncategorized
Age Group_Uncategorized
Author_Christian Behl
automatic-update
Category1=Non-Fiction
Category=GTR
Category=JMR
Category=MJN
Category=PSAN
COP=Switzerland
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€20 to €50
PS=Active
softlaunch

Alzheimers Disease Research: What Has Guided Research So Far and Why It Is High Time for a Paradigm Shift

English

By (author): Christian Behl

This book highlights the key phases and central findings of Alzheimers Disease research since the introduction of the label Alzheimers Disease in 1910. The author, Christian Behl, puts dementia research in the context of the respective zeitgeist and summarizes the paths that have led to the currently available Alzheimers drugs. As the reader is taken through the major developments in Alzheimer's Disease research, particularly over the past thirty years, Behl poses critical questions: Why are the exact causes of Alzheimer's Disease still in the dark, despite all the immense, worldwide research efforts in academia as well as in the pharmaceutical industry? Why has the majority of an entire research field kept focusing on a single hypothesis that establishes the deposition of the amyloid beta peptide in the brain as the key trigger of Alzheimer's pathology, even though this concept has still not been convincingly proven in the clinics? Are there other hypotheses that might explainthe pathogenesis of this complex brain disease, and if so, why were these perspectives not adequately followed?

In this book, Behl tries to answer these questions. Starting with the historical background, the author illustrates the long and arduous research journey, its numerous setbacks, and the many alternative explanations for the disease, which have started gaining increasing attention and acceptance in the Alzheimers research community only more recently. 

With his deep dive into the history and progression of this research, including the most recent developments, Behl explains why he believes that it is high time to promote a paradigm shift in Alzheimers Disease research.

The book is written for all researchers in the fields of neurobiology and neurodegeneration, as well as other biomedical fields, who would like to gain a broad and beyond the surface insight into (the key developments of) one of the most promoted research fields of our time. With its extensive literature references and over 100 illustrations, the book is also attractive for students and interested lay persons. Elaborating on all the different aspects and research approaches of this research field, the author aims to convince the reader that the underlying causes of Alzheimers Disease may be much more complex than previously thought and that this must be considered for future research directions. While he hopes that the Alzheimers research community is finally ready to shed its amyloid-straitjacket that has hampered progress for too long, he is also convinced that a much-needed paradigm shift can guide future Alzheimers Disease research and provide a new and broader perspective on this age-dependent brain disease.
See more
Current price €39.59
Original price €43.99
Save 10%
A01=Christian BehlAge Group_UncategorizedAuthor_Christian Behlautomatic-updateCategory1=Non-FictionCategory=GTRCategory=JMRCategory=MJNCategory=PSANCOP=SwitzerlandDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€20 to €50PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 155 x 235mm
  • Publication Date: 15 Jul 2024
  • Publisher: Springer International Publishing AG
  • Publication City/Country: Switzerland
  • Language: English
  • ISBN13: 9783031315725

About Christian Behl

Christian Behl is Professor of Pathobiochemistry and Director of the Institute of Pathobiochemistry at the University Medical Center of the Johannes Gutenberg University Mainz Germany. He has been closely following Alzheimers Disease research since the early 1990s when he first got involved into the field himself during his time at the Salk Institute for Biological Studies La Jolla USA. He stayed active in the field all through his research station at the Max Planck Institute of Psychiatry Munich Germany and later in Mainz. There his current research (in Mainz) focuses on the cellular degradation mechanism autophagy in the context of neurodegeneration and aging. For quite some time Behl has been an active advocate for widening the focus of Alzheimers Disease research to improve the understanding of this complex age-related brain disorder. Behl is member of several scientific boards including the German Alzheimer Foundation.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept